Eyenovia (EYEN)
(Real Time Quote from BATS)
$0.46 USD
0.00 (0.48%)
Updated Sep 24, 2024 01:12 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Price, Consensus and EPS Surprise
EYEN 0.46 0.00(0.48%)
Will EYEN be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for EYEN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EYEN
Eyenovia (EYEN) Upgraded to Buy: Here's What You Should Know
Eyenovia, Inc. (EYEN) Reports Q2 Loss, Misses Revenue Estimates
EYEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Eyenovia (EYEN) Rating Upgrade to Buy
Eyenovia (EYEN) Down 18% on Disappointing Corporate Update
Eyenovia, Inc. (EYEN) Reports Q4 Loss, Misses Revenue Estimates
Other News for EYEN
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization
Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.
Eyenovia announces Formosa granted Taiwan Export License
Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer
Eyenovia appoints Andrew Jones as CFO